Questions
CJC-1295 Ipamorelin: questions, answered from the record
Direct answers to what people actually ask, each pinned to the literature — and honest about where the data stop.
How long do CJC-1295 and Ipamorelin take to work?
The molecular signal is immediate; the measurable readout builds over days. A single subcutaneous dose of CJC-1295 (DAC) raised mean plasma GH 2- to 10-fold for six days or more and IGF-1 1.5- to 3-fold for nine to eleven days in healthy adults; after multiple doses IGF-1 stayed above baseline up to 28 days [1]. The ipamorelin GH pulse itself peaks within about forty minutes of a dose.
How long does Ipamorelin stay in your system?
In rodents, ipamorelin's half-life is under about two hours, with the GH response peaking near forty minutes; clearance is roughly five-fold slower than GHRP-6, and 60 to 80% of the dose is recovered in bile and urine [12]. No validated human half-life has been published. The CJC-1295 half is the long-acting one — roughly six to eight days for the DAC form [1].
What is the difference between CJC-1295 with DAC and no DAC?
The DAC (Drug Affinity Complex) covalently binds serum albumin, stretching CJC-1295's half-life to about six to eight days and raising GH and IGF-1 for days from one dose [1][5]. The no-DAC form, Mod GRF (1-29), omits that tag and lasts about thirty minutes, like native GHRH [11]. Same receptor, very different duration.
Can I take CJC-1295 / Ipamorelin every day?
This site does not give dosing schedules for any person. In research, CJC-1295 (DAC) was given in once-daily and multiple-dose regimens in human pharmacokinetic studies [1], and once-daily in GHRH-knockout mice [9]. Those are study protocols in named species, not recommendations — there is no established human dosing for the fixed blend, which was never trialed.
What is CJC-1295 / Ipamorelin good for?
In the literature, the pairing is studied as a way to raise the body's own growth hormone and IGF-1: CJC-1295 (DAC) raised GH 2- to 10-fold and IGF-1 1.5- to 3-fold for days in healthy adults [1], and adding a selective GH-releasing peptide like ipamorelin amplifies the GH pulse [3]. Downstream effects on body composition, recovery and sleep are extrapolated or community-reported, not established for the blend.
What are the bad side effects of CJC-1295 and Ipamorelin?
Ipamorelin is the first selective GH secretagogue: unlike GHRP-6 and GHRP-2 it did not raise ACTH or cortisol above GHRH-stimulated levels even at doses over 200x the ED50 for GH release [2], which is part of its appeal. Class-level concerns from raising GH are higher blood glucose from reduced insulin sensitivity, fluid retention and carpal-tunnel-type symptoms [6]. Community reports add injection-site reactions and post-injection flushing — anecdotal, not clinical.
How many mg of CJC-1295 and Ipamorelin should I take?
This site does not provide human doses, and there is no established one — the fixed blend has never been studied in a controlled human trial. The literature records research doses only, attributed to species and route (for example, CJC-1295 at 30 to 90 µg/kg subcutaneously in human pharmacokinetic studies [1]). Those are study figures, not a recommendation.
Does CJC-1295 raise testosterone?
There is no evidence in this literature that CJC-1295 raises testosterone; it acts on the GHRH receptor to raise growth hormone and, downstream, IGF-1 [1]. Its documented effects run through the GH/IGF-1 axis, not the gonadal axis. Any claim that this pairing boosts testosterone is not supported by the cited studies.
Does Ipamorelin reduce belly fat?
Not established for ipamorelin or the blend. The strongest visceral-fat evidence in the GH-axis space belongs to a different compound, the GHRH analogue tesamorelin: a 2026 meta-analysis of five RCTs found reduced visceral adipose tissue (−27.71 cm²) and hepatic fat (−4.28%) [7]. That is read-across context for the GHRH arm, not data on ipamorelin, which also showed a GH-independent adipogenic effect in some mice.
What are the downsides to CJC-1295 / Ipamorelin?
The main documented downsides are class-level: a higher GH signal can raise blood glucose by reducing insulin sensitivity, and can cause fluid retention and carpal-tunnel-type symptoms [6]. Add the honest gaps — no controlled human trial of the blend, no validated human pharmacokinetics for ipamorelin, and unverified purity in research-grade supply. Ipamorelin's own selectivity (no cortisol/ACTH spike) is a genuine upside that offsets some older-peptide concerns [2].
Which is better, Sermorelin or Ipamorelin?
Neither is "better" in a head-to-head sense — they are different tools. Sermorelin is a short-acting GHRH analogue; ipamorelin is a selective GH-releasing peptide acting on the separate ghrelin receptor. They are the two arms a combination pairs, and combining a GHRH with a GH-releasing peptide is what the synergy literature recommends [3]. No controlled human trial compares them directly.
Can you take both Sermorelin and Ipamorelin together?
Combining a GHRH analogue with a GH-releasing peptide is exactly the pairing strategy the synergy literature describes: in normal men, submaximal GH-releasing-peptide doses combined with GHRH stimulated GH release synergistically through independent mechanisms [3]. This is the same logic behind the CJC-1295 + ipamorelin stack. Whether to do so is a clinical decision this editorial site does not make or advise on.
Is Tesamorelin better than Ipamorelin?
They are different classes with different evidence. Tesamorelin is a GHRH analogue with strong randomized-trial data for visceral and hepatic fat reduction: a 2026 meta-analysis of five RCTs reported −27.71 cm² visceral fat and −4.28% hepatic fat [7]. Ipamorelin is a selective GH-releasing peptide with mostly rodent data and no validated human pharmacokinetics [12]. "Better" depends entirely on the endpoint, and no trial compares them.
Is Ipamorelin stronger than Sermorelin?
There is no controlled human comparison, so "stronger" cannot be answered from data. Mechanistically they pull different levers — ipamorelin the ghrelin receptor, sermorelin the GHRH receptor — and the synergy literature suggests the two together exceed either alone [3]. Ipamorelin's defining trait is selectivity: a GH pulse without an ACTH or cortisol rise even at very high doses [2].
Which is safer, Sermorelin or Ipamorelin?
Neither has a controlled human safety comparison. Ipamorelin's notable safety feature is selectivity — it did not raise ACTH or cortisol above GHRH-stimulated levels even at doses over 200x the ED50 for GH release [2]. Both share the class-level concern of any GH secretagogue: increased blood glucose from reduced insulin sensitivity, with long-term data still needed [6].
What is CJC-1295 / Ipamorelin?
It is a research pairing of two peptides that raise the body's own growth hormone: CJC-1295, a long-acting GHRH analogue, and ipamorelin, a selective GH-releasing peptide (a ghrelin-receptor agonist). Because they act through independent pathways, together they produce a larger GH pulse than either alone [3][4]. Neither is FDA-approved, and the fixed blend has never been trialed.
How much CJC-1295 / Ipamorelin should I take?
This site does not answer that, and no validated human dose exists — the blend has never been studied in a controlled human trial. The literature records research doses by species and route only; for example, CJC-1295 was given at 30 to 90 µg/kg subcutaneously in human pharmacokinetic studies [1]. That is a study figure, not guidance.
Is CJC-1295 / Ipamorelin safe?
There is no long-term human safety database for the fixed blend. The GH-secretagogue class is generally well tolerated short-term, with the chief concern being increased blood glucose from decreased insulin sensitivity and long-term cancer/mortality data still needed [6]. Ipamorelin's selectivity — no cortisol or ACTH rise even at very high doses [2] — is a genuine safety point, but "safe" here names an open question, not a settled answer.
Does CJC-1295 / Ipamorelin work?
For its direct, measured effect — raising GH and IGF-1 — the single-component evidence is solid: CJC-1295 (DAC) raised mean plasma GH 2- to 10-fold for six or more days and IGF-1 1.5- to 3-fold for nine to eleven days in healthy adults [1]. Whether the blend produces the downstream body-composition results people want is not established, because the combination was never trialed.
Is Ipamorelin FDA approved?
No. Neither ipamorelin nor CJC-1295 holds FDA approval for any indication; both are sold only as research chemicals. A review of GH secretagogues found them well tolerated overall but emphasized that long-term data on cancer incidence and mortality are still needed [6]. Both are also WADA-prohibited at all times under Section S2.
How to reconstitute CJC-1295 / Ipamorelin (5mg)?
This site does not give preparation or injection instructions. As laboratory-handling context only: lyophilized peptide is reconstituted with bacteriostatic water (sterile water with 0.9% benzyl alcohol), kept refrigerated at 2–8 °C, and protected from agitation and repeated freeze-thaw, because aqueous solutions degrade over weeks via deamidation. That is storage chemistry from the literature, not a procedure to follow.
Where to inject CJC-1295 / Ipamorelin?
This site does not provide injection instructions or sites. In research, the routes studied for these compounds were subcutaneous and intravenous, with continuous subcutaneous infusion and intranasal routes used in some rodent pharmacokinetic work [12]. Those are study routes in named species, not directions for any person to administer anything.